BiomX

Microbiome Therapies for Chronic Diseases

Startup

BiomX is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2015. Microbiome Therapies for Chronic Diseases. The company has raised a total of $143.5M across 10 funding rounds, currently at the Public stage. BiomX was founded by Eran Elinav, Prof., Prof. Rotem Sorek, Tim Lu. Key investors include Deerfield Management, Cystic Fibrosis Foundation, OrbiMed, among 14 total investors. The company has 51-200 employees. Core technologies: Artificial Intelligence, Biologicals, Microorganisms.

With $143.5M in total funding, BiomX is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial.

$143.5M
Raised
10
Rounds
15
Investors
7
Team
2015
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentArtificial IntelligenceBiologicalsMicroorganisms
At a Glance
Investors

14 investors total

Founders
In the News

111 articles covered by sources including finance.yahoo.com, en.globes.co.il, www.marketscreener.com, pharmaphorum.com, www.globenewswire.com.

finance.yahoo.com · Oct 17, 2025
BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
Read article ↗
Frequently Asked Questions
What does BiomX do?

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis, and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. The company's platforms use computational and synthetic biology and research from Doctors Rotem Sorek, Eran Elinav, and Eran Segal of the Weizmann Institute of Science and Doctor Timothy K. Lu of the Massachusetts Institute of Technology.

How much funding has BiomX raised?

BiomX has raised $143.5M in total funding across 10 rounds. The company is currently at the Public stage. Key investors include Deerfield Management, Cystic Fibrosis Foundation, OrbiMed.

Who founded BiomX?

BiomX was founded in 2015 by Eran Elinav, Prof. (Scientific Founder), Prof. Rotem Sorek (Scientific Founder), Tim Lu (Co-founder).

What sector is BiomX in?

BiomX operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Artificial Intelligence, Biologicals, Microorganisms. Target customers: Healthcare & Life Sciences, Life Sciences, Cosmetics, Pharmaceuticals, Healthcare, Patients.

Where is BiomX located?

BiomX is based in Einstein St 22, Ness Ziona, Israel, Center District.

View Full Profile Classic View Website ↗